Business
Press Release Aug 02 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated August 02, 2023, titled "Strides reports highest ever EBITDA, INR 1,686m in Q1FY24".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated August 02, 2023, titled "Strides reports highest ever EBITDA, INR 1,686m in Q1FY24". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd